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Background: Although the benefits of physical activity (PA) on to prevent and manage non-communicable
diseases are well known, strategies to help increase the levels of PA among different populations are limited.
Exercise-referral schemes have emerged as one effective approach to promote PA; however, there is uncertainty
about the feasibility and effectiveness of these schemes in settings outside high-income countries. This study will
examine the effectiveness of a scheme to refer hypertensive patients identified in Primary Health Care facilities (PHCU)
of the Mexican social security institution to a group PA program offered in the same institution.
Methods and design: We will describe the methods of a cluster randomized trial study designed to evaluate the
effectiveness of an exercise referral scheme to increasing physical activity in hypertensive patients compared to a
non-referral scheme. Four PHCU were selected for the study; the PHCU will take part as the unit of randomization and
sedentary hypertensive patients as the unit of assessment. 2 PHCU of control group (GC) will provide information to
hypertensive patients about physical activity benefits and ways to increase it safely. 2 PHCU of intervention group (IG)
will refer patients to sports facilities at the same institution, to follow a group-based PA program developed to increase
the PA levels with a designed based on the Transtheoretical Model and Social Cognitive Theory. To evaluate the effects
of the intervention as well as short-term maintenance of the intervention’s effects, PA will be assessed at baseline, at 24
and 32 weeks of follow-up.
The main outcome will be the difference before and after intervention in the percentage of participants meeting
recommended levels of PA between and within intervention and control groups. PA will be measured through
self-report and with objective measure by accelerometer.
Discussion: This study will allow us to evaluate a multidisciplinary effort to link the primary care and community-based
areas of the same health care system. Our findings will provide important information about the feasibility
and effectiveness of an exercise-referral scheme and will be useful for decision-making about the implementation
of strategies for increasing PA among hypertensive and other clinical populations in Mexico and Latin America.
Trial registration: Clinicaltrials.gov Identifier: NCT01910935. Date of registration: 07/05/2013.
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The benefits of physical activity (PA) on health have been
well documented [1-3]. However, a large proportion of the
world population fails to meet current global physical ac-
tivity recommendations (at least 150 minutes of moderate-
to-vigorous PA/week) [4]. In 2010 the global prevalence of
inactivity was estimated at 32%, and as much as 40% of
the population in the Americas [5]. In Mexico, the preva-
lence of physical inactivity has increased 6%, from 13.4%
to 19.4% in only six years [6].
Globally, the magnitude of the physical inactivity prob-
lem is worse in poorer regions of the world. For ex-
ample, until 80% of mortality due to NCD’s and physical
inactivity occurs in lower-middle income countries.7 As
part of the strategies developed to prevent and control
NCDs, Mexico’s Social Security Institution (MSSI), which
covers 49.2% of the Mexican population, is providing
comprehensive health care and referrals for PA programs
for patients [7]. However, 16.8% are physical inactive and
in a whole 83% of do not meet PA recommendations [8].
Increasing physical activity to recommended levels would
help eliminate 6% to 10% of the major Non-Communicable
Diseases (NCDs), including coronary heart disease (CHD),
type 2 diabetes, breast and colon cancers [9]. Physical
inactivity contributes to and aggravates NCDs like hyper-
tension (HTN), [10] which constitutes the leading cause
of NCD visits at the MSSI, [11] and the proportion of
newly diagnosed MSSI patients with HTN has increased
by 30% in only five years [12]. Complications associated
with HTN consume between 6 and 8% of the total health
care expenditure of the Mexican health system [11,13].
Adding physical activity to the HTN medical treatment
paradigm for HTN can help control blood pressure, re-
duce mortality and complications and help curb the health
care [14].
The Primary Health Care (PHC) setting has been identi-
fied as a base for PA-promotion strategies since it is a point
of contact with hypertensive patients, and since basing
interventions there would facilitate the continuity of care
and integration of multiple disciplines into treatment [15].
PHC physicians have been seen as source of health promo-
tion and powerful agents for physical activity promotion
[16]. However, through the years strategies focusing exclu-
sively on physician involvement have had little success.
Insufficient health promotion training, lack of time of
medical consultation, and lack of physician confidence
that their recommendations for healthy lifestyles are useful
for patients, has been the aim barriers to achieve it [17-19].
Therefore, it appears that PA counseling and PHC-based
PA-referral schemes as an inclusive strategy utilizing avail-
able staff and facility resources to help people to become
physically active might function better in this settings,
since both have proven effective in helping inactive people
to meet PA recommendations [20-22].Systematic reviews of exercise-referral schemes dem-
onstrate that challenges remain in terms of increasing
patients’ acceptance of and adherence to PA programs
[19-23]. However the results of these studies are from
high-income countries, and little is known about effect-
ive ways to increase PA in countries with different in-
come levels. These lower income countries are the focus
of only 10% of the global research but house 90% of the
world’s population [24]. If lifestyle changes such as in-
creasing PA practice are to be implemented worldwide,
it is essential to understand the mechanisms underlying
the behavior of diverse populations.
In the context of studies about effectiveness of PA-
referral schemes, to date there is lack of proven evidence
of its effectiveness with objective outcome measures of PA
[25], since interventions’ effects have been documented
exclusively by self-report [21,26]. Therefore, this study
will estimate the effectiveness of PA referral scheme
with an objective PA assessment. This will be the first
study of PA-referral scheme for chronically ill patients in
the Mexican Health System.
The aim of this study is to evaluate the effectiveness of
an MSSI PHC-based physician to a PA- referral scheme
designed to help chronically ill patients to increase PA,
in order to perform recommended levels of PA (150 mi-
nutes at week of moderate to vigorous intensity).
Methods and design
Setting
The Mexican Social Security Institute (MSSI) includes
offices for primary, secondary and tertiary health services
as well as facilities designed to develop PA programs (sports
fields, gyms, pools and outdoor spaces for PA) called
Social Security Centers (SCC). The SCC have specialized
staff to guide and assist on promotion and practice PA in
all potential participants.
Design and recruitment process
This is a cluster randomized trial, with the primary health
care unit (PHCU) as the unit of randomization and hyper-
tensive patients as the unit of assessment, to evaluate the
impact of a PA-referral scheme to help patients increase
their PA levels and meet recommended PA guidelines.
Four MSSI PHCU facilities will be assigned in a random-
ized way to intervention (2 PHCUs) and control groups
(2 PHCUs). In all PHCUs, primary care physicians will
identify hypertensive patients based on the following
criteria: women and men with MSSI affiliation, between
35 and 70 years old, less than 5 years from hypertension
diagnosis and/or without pharmacological treatment self-
reporting willingness to engage in a PA program but cur-
rently not meeting PA recommendations (< 150 minutes
per week of moderate to vigorous intensity PA). Using a
standardized protocol, physicians will quickly screen for
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suite, located in the same PHCU facility. Trained staff will
verify that potential participants meet the inclusion
criteria described below, to confirm that they can safely
engage in the PA program.
Inclusion criteria:
a) Adults between 35 and 70 years old; b) both sexes;
c) patients with hypertension diagnosis within five years or
less and/or without pharmacological therapy for hyperten-
sion (according with JNC 7 criteria) [27]; d) Not meeting
PA recommendations (<150 minutes at week of moderate
or vigorous intensity), as measured with the short-form of
the International Physical Activity Questionnaire (IPAQ)
[28]; e) currently in the contemplation or preparation stage
for PA, according to Transtheoretical model of behavioural
change [29]; f) low to moderate level of cardiovascular risk,
according to the Guidelines for exercise testing and recom-
mendations of the American College of Sports Medicine
(ACSM) [30]. A pre-participation screening questionnaire
from American College of Sports Medicine (ACSM) and
ACSM [31], will be used to evaluate health status, medical
history of cardiovascular, metabolic or lung disease, signs
or symptoms suggestive of these conditions and num-
ber of cardiovascular risk factors. Symptoms that re-
quire a complex evaluation will be confirmed by medical
staff; g) blood pressure levels: systolic blood pressure
levels ≤ 160 mm Hg or diastolic ≤ 100 mm Hg [32,33];
[h) Body Mass Index < 35; i) biochemical markers in the
following ranges: total cholesterol ≤ 240 mg/dL, fasting
glucose level ≤ 126 mg/dL, triglycerides ≤ 150 mg/dL;
j) physical ability to participate in the PA program (with-
out problems that may impede walking or other moderate
intensity PA).
Exclusion criteria:
For both the control and intervention groups: cur-
rently reporting high levels of PA (> 300 minutes at week
of moderate to vigorous intensity) [34], having previously
attended a PA program at MSSI facilities. Criteria during
PA sessions in the intervention group: systolic/diastolic
blood pressure prior to PA sessions > 200/100 mm Hg or
during the session > 250/115 mm Hg. The elimination cri-
teria proposed are: less than 80% PA program attendance
with or without incomplete information in one of the
three data-collection points in the study.
The study’s recruitment process is schematized in
Figure 1. Patients who meet the criteria previously
described will be invited to participate. Patients accepting
to participate will provide informed consent and will be
formally enrolled.
Randomization
Randomization will be performed before other study activ-
ities, and conducted at MSSI facilities outside the PHCUs
to avoid contamination. The 4 PHCUs were randomizedinto the intervention group (IG; 2 centers) and control
group (CG; 2 centers) using sealed envelopes by a health
researcher who was not involved in this study. To avoid
contamination, that PHCUs selected, are on average 5.5
kilometers (kms) from the place where patients will be
referred (IG at 5.1 kms. and CG at 6.6 kms.), within the
urban area of the city and public transportation available,
average transfer time is 20 to 30 minutes.
Baseline assessment
During this assessment a questionnaire will be adminis-
tered and functional capacity measurements will be taken.
To evaluate the effects of the intervention, measurements
will be taken at baseline, at 24 weeks of study entry base-
line, to assess adherence to the intervention, and at
32 weeks of study entry, to determine short-term mainten-
ance of the intervention’s effects. Details of study’s design
and flow chart are showed in Figure 2. A trained nurse,
part of the research team, will carry out this assessment,
duration between 40 to 60 minutes.
Control group (CG)
Participants in the control group will be informed about
health benefits of PA and a balanced diet, and how to safely
increase PA levels. Patients in this group will continue receiv-
ing their usual care at PHCU facilities. The control group
will be invited to undergo two subsequent PA assessments at
the PHCU facilities at 24 and 32 weeks of follow-up. The
research team will keep in contact with these patients dur-
ing monthly doctor’s appointment or through a monthly
phone call to emphasize the participation in the study and
with appointment reminders at weeks 22 and 30.
Intervention group (IG)
The group-based PA program developed to increase the
PA levels of hypertensive patients was designed based
on the Transtheoretical Model [29] and Social Cognitive
Theory [35,36].
The components of the 24 week PA program are:
duration (60 minutes per session), frequency (3 times per
week), and intensity (moderate to vigorous). The program
will be conducted and supervised by trained staff with
experience in handling groups of patients with chronic
conditions like diabetes and hypertension; therefore, only
typical embodiments of exercise like dancing, supervised
walking and swimming will be included.
Implementation
Patients in the IG, will be invited for following activities
during the first three sessions of the PA program at the
SCC:
1) Select and enroll in their PA group. Each group will start
with a minimum of 5 patients and a maximum of 20.
Figure 1 Recruitment flowchart.
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during the intervention, depending on the flow of
participants. Patient groups were organized based on
personal preferences of exercise and for patients with
joint or bone problems, swimming will be recommended.
2) During the first session, MSSI staff trained in guiding
the PA program will administer the functional capacity
test, to personalize the PA prescription and determine
the PA intensity each patient will be instructed to
exercise at the start of the program. PA intensity will be
increased gradually, depending on patient
characteristics and training progression for each
patient. PA prescription will start at 55% of the patient’s
maximum heart rate (MHR), and gradually increase to
75% of MHR to enhance safety and efficacy. The
trained staff will instruct patients how to monitor their
heart rate before, during and after PA sessions and to
be alert to fluctuations outside the ranges. A general
description of the PA program progression follows.
Level 1 or induction: between the initial 4 to 6 weeks,
during which the patients will adopt a regular exercise
habit.Level 2 or development: during weeks 7 to 12 in which
there will be a gradual increase in exercise volume (dur-
ation and intensity) every 2 weeks.
Level 3 or maintenance: beginning at the 13th week,
when the patient has started to reach an improved level
of functional capacity and exercise tolerance, allowing
him or her to maintain the same routine in duration and
intensity during group-based exercise classes, while
improving free-living and other recreational PA as part
of their lifestyle sessions the following weeks.
3) The group-based PA sessions will consist of three
stages: warm-up, predominantly aerobic exercise, and
recovery. The components of PA program are shown in
Table 1. The trained staff will also record participants’
self-reported recreational PA outside the SCC.
Outcome assessment
Primary outcomes
The main outcome will be the difference before and after
intervention in the percentage of participants meeting rec-
ommended levels of PA (at least 150 minutes at week
of moderate to vigorous intensity) [1,2], between and
within intervention and control groups. Based on previous
Figure 2 Study design flowchart.
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be considered effective if it achieves an increase of 20%
in the proportion of hypertensive patients in the interven-
tion group defined as active compared to control group, at
the end of the intervention (24 weeks) to evaluate adher-
ence and at 32 weeks to assess the sustainability of inter-
vention effects.
PA levels will be assessed at three time points during
the study to determine changes in the following: percent-
age of participants meeting the PA recommendation, mi-
nutes of moderate and vigorous PA performed per week
and minutes per day of sedentary behavior. In the inter-
vention group, we will also measure change over time
in the following tests of functional capacity: walking dis-
tance (6 minute walk test) [37], maximum heart rate and1 minute heart-rate recovery [38]; these measurements
will be taken at baseline, 24 and 32 weeks too. These vari-
ables will be used as a complementary assessment of
participant’s functional capacity and not as the primary
outcome of the study.
Secondary outcomes
Outcomes assessed in the intervention and control groups
at 24 and 32 weeks will be: a) blood pressure levels; b)
biochemical markers: triglycerides, total cholesterol and
HDL, fasting glucose; c) anthropometric measures: weight,
BMI, hip and waist circumference to calculate waist/hip
ratio; d) social/psychological measures: attitude towards
PA participation based on Prochaska’s stages of change
model [29], PA self-efficacy [39] health related quality of
Table 1 Components of physical activity program









Warm-up phase: Involving all parts of the body: neck,
upper limbs, lower limbs
10 minutes, 50% of MHR 10 minutes, 50% of MHR 10 minutes, (MHR) 50%
Aerobic phase: Walking, running, dancing or bicycling. 20 minutes (THR) 55% 30 minutes (THR) 55-75% 40 minutes (THR) 60-75%
Recovery phase: Gradually reduce the intensity. Stretch,
bend and rotate body parts starting with the neck and
concluding with the ankles, emphasizing deep breathing.
5-10 minutes 5-10 minutes 5-10 minutes
MHR: Maximum heart rate (220-age). THR: Training Heart Rate.
Reference: Fox III, SM Naughton, JP and Haskell, WL. Physical activity and the prevention of coronary heart disease. Ann Clin Res 1971; 3:404-432.
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version) [41] and social support for PA participation.
Measurements
Several kinds of data will be collected to measure the
intervention’s effects. Measurement procedures are
described here:
Physical activity measurement
Amount of PA will be measured with objective and self-
report instruments.
Objective: Participants will be monitored via ActiGraph
GT3X accelerometers (ActiGraph LLC, Ft. Walton Beach,
Florida) while exercising. This device has an internal time
clock and extended memory, and is able to record and
store the magnitude of acceleration and deceleration of
movements. The recorded data is scored as a “count”,
which can be summed in a specific time interval called an
“epoch”. In this study, an epoch will equal sixty seconds.
Participants will be instructed to wear the device for 7 days
during all waking hours, and to remove it only during
swimming, bathing or other contact with water. The ac-
celerometers will be mounted on elastic belts and placed
at the right hip. For this study the wear time will be valid,
if the patient wears the device for 5 days in one week
(including at least 1 weekend day) to accumulate at least
600 minutes daily.
Each patient’s accelerometer record will be analyzed in
terms of time (in minutes) performing moderate to vig-
orous PA per day, to calculate the average time spent (in
minutes) of PA during the week. Using this data, we will
categorize patients as complying or not complying with
recommended levels of PA [2], (150 minutes of PA moder-
ate to vigorous intensity at week) at the different measure-
ment points (baseline, 24 and 32 weeks to IG and baseline
and 24 weeks to CG) during the study.
Self-report instrument: PA levels during leisure time
will be measured with the short version of the Inter-
national Physical Activity Questionnaire (IPAQ) [28].
The IPAQ will be used to confirm the patients’ PA levels
at screening and at the study measurement points, and




1) Blood pressure levels: will be measured with a digital
instrument following criteria established by the JNC 7
[27]; 2) Fasting glucose levels: blood samples will be
taken following a fasting period of at least of 8 hours.
The serum glucose determination will be made using
the enzymatic calorimetric method. All blood biochem-
istry tests, including total cholesterol, high density lipids
(HDL), and triglycerides will be conducted with a Selec-
tra XL (Randox) in accordance with the procedures of
the International Federation of Clinical Chemistry and
Laboratory Medicine [42].
Anthropometric measurements
Will be carry out by trained nurses, following standard
procedures: 1) Weight: will be measured with a TANITA
electronic scale, with participants wearing minimal clothes
and without shoes; 2) Height: will be measured with a
conventional stadiometer, with participants standing with-
out shoes; 3) Body Mass Index (BMI): will be calculated
by dividing kilograms by height in meters squared. The
data obtained will be categorized according to the follow-
ing criteria: normal (BMI = 18.5-24.9 kg/m2), overweight
(BMI = 25–29.9 kg/m2) and obese (BMI = ≥ 30 kg/m2)
[43] 4). Waist circumference: measured at the highest
point of the iliac crest at the end of expiration, to the near-
est measuring tape point of 0.1 cm. The criteria for
abdominal obesity will be: men > 100 cm and women >
88 cm [44] 5); Hip circumference: Participants will be
standing with feet separated about 20 cm and weight dis-
tributed evenly on both feet, at level of the maximum extent
of gluteus in a horizontal plane, verifies that the measuring
tape covers at same high the perimeter of the body, near
to the skin but without compress [45].
Demographic, health history and lifestyle measurements
At the three measurement points of the study, partici-
pants will complete questionnaires asking about sex, age,
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their current, past and family history of hypertension,
history of other chronic conditions and diseases, current
pharmacological treatments, food intake, tobacco and
alcohol consumption. In addition, participants’ attitudes
toward behavior change based on Prochaska’s stages [29]
and self-efficacy regarding PA behavior change [35,36,39].
Health-related quality of life (SF-12) [40], symptoms of de-
pression (CES-D) [41] and social support will be assessed.
Sections of the questionnaire (variables that could change
between measurements), will be applied at the study’s three
measurement points, to both the control and intervention
groups.
Data management
All the information provided by participants will be su-
pervised by the research team, and also by independent
researchers. Questionnaires and clinical test results will
be directly captured in a customized Microsoft Access
database at the time of the interview with the participant
and at the delivery of clinical test results to the patient.
Information from other sources (daily PA, attendance rec-
ord) will also be captured in the customized Microsoft
Access database.
Sample size
On average, 17% of hypertensive patients at the MSSI meet
PA recommendations. (Gallegos-Carrillo K, Salmeron J,
Duran-Arenas L: Physical activity and diet counseling to
hypertensive patients among Mexican Primary care physi-
cians/forthcoming). Our sample size estimation is based
on the aim to increase from 17% to 37% the proportion of
patients meeting PA standards. To detect a PA difference
of 20% in this population, with a power of 90%, and a level
of significance of α = 0.05, 68 patients are required in each
group (IG and CG). Considering that patients involved in
this type of research have high dropout rates [46], to
achieve these 68 participants we will increase our initial
estimates of sample size by 40%. The study will thus enroll
224 hypertensive patients, 112 each in IG and CG.
Statistical analysis
Analysis of effectiveness will be carried out according to
an intention to treat analysis.
A baseline comparability analysis will be carried out
among the IG and CG, in relation to the variables studied
during the three measurement points in the study (0, 24
and 32 weeks). To compare means, T-test or analysis of
variance will be conducted, while Mann–Whitney tests
will be used to compare variables without a normal distri-
bution. Analysis of covariance will be conducted to assess
variables with repeated measures along the study.
Longitudinal generalized mixed models will be devel-
oped to account for the repeated measurements (0, 24and 32 weeks) for each patient. These models will be
linear for continuous changes in PA (minutes), and
logistic for categorical PA variables.
For the primary outcome variable, models will be ad-
justed for potential confounding variables that may alter
the proportion of patients who meet the minimum rec-
ommendation for PA: a) geographic accessibility barriers
(e.g. distance to SCC); b) financial (e.g. self-report of
financial resources to pay for transportation); c) adminis-
trative (e.g. SCC schedules not being compatible with
patient’s reported schedules); d) social support (e.g. help
with transportation to the SCC); e) conditions of patient
(for example: greater physical fitness than other hyper-
tensive patients, discomfort or injury discouraging par-
ticipation in the program, presence of acute or chronic
diseases).
In order to minimize regression bias to the estimated
mean, baseline values for each dependent variable will
be included in each regression model [47].
Cost-effectiveness analysis
Information about participants’ use of health care services
and program costs will be collected during the study, to
be used in subsequent cost-effectiveness analysis in the
event that the intervention proves effective.
Ethical issues
This study and all its procedures were approved by
the Scientific Research National Commission and Ethics
Committee of the MSSI. It should be noted that participa-
tion in the study is voluntary and participants may with-
draw at any time without affecting the health care services
they receive in any way. The information obtained as part
of this study will be strictly confidential, including identi-
fying data (name, phone and address). Personal data will
be stored separately to maintain the confidentiality of
medical history, questionnaire and clinical test results.
Discussion
Physical inactivity is highly prevalent worldwide and
contributes to the development of the leading non-
communicable diseases, a critical health challenge cur-
rently faced by lower-middle and upper-middle income
countries [7,48]. Now more than ever, these countries re-
quire evidence of locally-effective strategies that can help
increase activity levels by meeting population-specific
needs, which will reduce the impact of non-communicable
disease on national health systems.
Community-based PA promotion programs have been
developed in Latin American over the past few years. Re-
sults of systematic reviews [49,50] show that several coun-
tries, including Brazil, have carried out PA promotions in
community and school settings with encouraging results.
In addition, projects like GUIA [51] (Guide for Useful
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motion by helping to translate research findings into practice.
However, integrated community-based and clinical ap-
proaches are also needed will be needed to reducing phys-
ical inactivity in specific populations [52]. PHC-based
strategies have gained acceptance particularly among clin-
ical populations with high levels of non-communicable
disease risk factors, because they target a large percentage
of the population that actually uses healthcare services.
Counseling and referral schemes have been proven to in-
crease the numbers of people meeting PA recommenda-
tions [20-23]. However, evidence regarding such programs
is concentrated in high-income countries [53].
The present study will explore the effectiveness of PHC-
based intervention in a middle-income country setting,
assessing a strategy for linking clinical and community
health program areas within the same institution and de-
termining the feasibility of this multidisciplinary program’s
approach as a potential model to replicate. We will test the
effectiveness of a group program for increasing hyperten-
sive patients’ PA engagement, feasible at the IMSS because
it contains both medical and physical activity centers,
making clinician referral to free PA resources possible.
Evidence from self-reports indicates that referral schemes
are effective in increasing PA as measured by self-reports.
Yet, information on referral programs’ influence on pa-
tient’s PA, measured via objective method is lacking [22,54].
This study will be the first to use direct measurements of
PA to show the effects of an exercise-referral scheme in
real-world settings. Although we are aware of the limita-
tions posed by the study’s short duration, this does not
compromise its utility for physical activity promotion in
patients with chronic conditions.
If this intervention is found to be effective, the informa-
tion could useful to optimize resources. For example, to
design programs according to different stages of change,
proposing differentiated actions for patients in each one of
the stages, as stated in the transtheoretical model [29].
Namely, carry out actions to encourage the willingness to
change for patients in pre-contemplation stages or to
strengthen their physically active behavior for patients in
maintenance stage.
The study population is sharing characteristics such as
initially sedentary lifestyle, willingness to engage in PA, and
recent hypertension diagnosis. Sharing these traits could
encourage the group to develop a sense of community
which would promote self-efficacy and social support [55],
a fundamental feature of successful behavior change ac-
cording to social cognitive theory [35,36].
To ensure the quality of this study, the clinical trial
guidelines developed by the CONSORT group will be
followed [56]. We will be able to identify the number of
patients at the three measurement phases of the study and
conduct the analysis according to intention to treat.Finally, this assessment of effectiveness in the real-life
conditions of the IMSS health and social services facil-
ities, will serve as a baseline for these types of interven-
tion studies in the context of Latin America, where the
ability to test the feasibility, adherence and sustainability
of an exercise-referral scheme has not been explored.
While this study is an effort to try to improve partici-
pants’ health and the quality of life through PA promotion,
we are aware that this kind of initiative does not address
the root causes of physical inactivity. This problem will
persist unless both PA behaviors and the causes of inactiv-
ity change, a situation which requires approaches focused
not only on individual behavior, but also on complex
population-level systems and interactions [57].
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